Glaucoma Market Size, Share, Trends, Industry Analysis Report: By Disease Type, Drug Class, Distribution Channel, and Region

Description

List of Tables

The glaucoma market size is expected to reach USD 13.43 billion by 2034, according to a new study by Polaris Market Research. The report "Glaucoma Market Size, Share, Trends, Industry Analysis Report: By Disease Type (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), Drug Class, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Glaucoma is a group of eye diseases that cause damage to the optic nerve, often due to increased intraocular pressure, leading to vision loss if left untreated. The glaucoma market demand is growing due to an aging global population, as the risk of glaucoma increases with age. Rising awareness about the disease, advancements in diagnostic technologies, and an increasing number of treatment options are also driving the glaucoma market growth.

Key glaucoma market opportunities include the development of novel drug delivery systems, minimally invasive surgeries, and AI-based diagnostic tools. Additionally, combination therapies and telemedicine are emerging trends. Regulatory support and favorable reimbursement policies are further boosting market expansion, ensuring access to treatments, and encouraging ongoing innovation in glaucoma care.

Glaucoma Market Report Highlights

The open angle glaucoma segment, by disease type, held the largest glaucoma market share in 2024 due to its higher prevalence, driven by the aging population and increasing incidence of chronic conditions. However, the angle closure glaucoma segment is showing the fastest growth, aided by better diagnostic capabilities and increasing awareness.
The prostaglandins analogs segment, by drug class, dominated the market in 2024, as it is considered the first-line treatment for glaucoma due to its effectiveness in lowering intraocular pressure.
North America dominated the glaucoma market revenue share in 2024 due to advanced healthcare infrastructure and higher treatment awareness. Asia Pacific is the fastest-growing region, fueled by increasing healthcare access, a rising geriatric population, and government healthcare initiatives.
The market comprises several key players actively involved in developing and providing treatments for this eye condition. Notable companies include Novartis AG; Pfizer Inc.; Merck & Co., Inc.; Bausch & Lomb Incorporated; Allergan plc; and Teva Pharmaceutical Industries Ltd. These organizations contribute significantly to the availability of various therapeutic options for glaucoma patients.

Polaris Market Research has segmented the glaucoma market report on the basis of disease type, drug class, distribution channel, and region:

By Disease Type Outlook (Revenue - USD Billion, 2020-2034)

Open Angle Glaucoma
Angle Closure Glaucoma
Others

By Drug Class Outlook (Revenue - USD Billion, 2020-2034)

Prostaglandins Analogs
Beta-blockers
Adrenergic Agonists
Carbonic Anhydrase Inhibitors
Others

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1366

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Glaucoma Market Insights

4.1. Glaucoma Market - Market Snapshot
4.2. Glaucoma Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.2. Restraints and Challenges
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Glaucoma Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Glaucoma Market, by Disease Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
5.3. Open Angle Glaucoma
- 5.3.1. Global Glaucoma Market, by Open Angle Glaucoma, by Region, 2020-2034 (USD Billion)
5.4. Angle Closure Glaucoma
- 5.4.1. Global Glaucoma Market, by Angle Closure Glaucoma, by Region, 2020-2034 (USD Billion)
5.5. Others
- 5.5.1. Global Glaucoma Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Glaucoma Market, by Drug Class

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
6.3. Prostaglandins Analogs
- 6.3.1. Global Glaucoma Market, by Prostaglandins Analogs, by Region, 2020-2034 (USD Billion)
6.4. Beta-blockers
- 6.4.1. Global Glaucoma Market, by Beta-blockers, by Region, 2020-2034 (USD Billion)
6.5. Adrenergic Agonists
- 6.5.1. Global Glaucoma Market, by Adrenergic Agonists, by Region, 2020-2034 (USD Billion)
6.6. Carbonic Anhydrase Inhibitors
- 6.6.1. Global Glaucoma Market, by Carbonic Anhydrase Inhibitors, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Glaucoma Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Glaucoma Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Hospital Pharmacy
- 7.3.1. Global Glaucoma Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
7.4. Retail Pharmacy
- 7.4.1. Global Glaucoma Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacy
- 7.5.1. Global Glaucoma Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Glaucoma Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Glaucoma Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Glaucoma Market - North America
- 8.3.1. North America: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
- 8.3.3. North America: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4. Glaucoma Market - U.S.
  - 8.3.4.1. U.S.: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5. Glaucoma Market - Canada
  - 8.3.5.1. Canada: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4. Glaucoma Market - Europe
- 8.4.1. Europe: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
- 8.4.3. Europe: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4. Glaucoma Market - UK
  - 8.4.4.1. UK: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5. Glaucoma Market - France
  - 8.4.5.1. France: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6. Glaucoma Market - Germany
  - 8.4.6.1. Germany: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7. Glaucoma Market - Italy
  - 8.4.7.1. Italy: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8. Glaucoma Market - Spain
  - 8.4.8.1. Spain: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9. Glaucoma Market - Netherlands
  - 8.4.9.1. Netherlands: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10. Glaucoma Market - Russia
  - 8.4.10.1. Russia: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11. Glaucoma Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5. Glaucoma Market - Asia Pacific
- 8.5.1. Asia Pacific: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4. Glaucoma Market - China
  - 8.5.4.1. China: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5. Glaucoma Market - India
  - 8.5.5.1. India: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6. Glaucoma Market - Malaysia
  - 8.5.6.1. Malaysia: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7. Glaucoma Market - Japan
  - 8.5.7.1. Japan: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8. Glaucoma Market - Indonesia
  - 8.5.8.1. Indonesia: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9. Glaucoma Market - South Korea
  - 8.5.9.1. South Korea: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10. Glaucoma Market - Australia
  - 8.5.10.1. Australia: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11. Glaucoma Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6. Glaucoma Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4. Glaucoma Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5. Glaucoma Market - UAE
  - 8.6.5.1. UAE: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6. Glaucoma Market - Israel
  - 8.6.6.1. Israel: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7. Glaucoma Market - South Africa
  - 8.6.7.1. South Africa: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8. Glaucoma Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7. Glaucoma Market - Latin America
- 8.7.1. Latin America: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4. Glaucoma Market - Mexico
  - 8.7.4.1. Mexico: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5. Glaucoma Market - Brazil
  - 8.7.5.1. Brazil: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6. Glaucoma Market - Argentina
  - 8.7.6.1. Argentina: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7. Glaucoma Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Glaucoma Market, by Disease Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Glaucoma Market, by Drug Class, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Glaucoma Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Novartis AG
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Pfizer Inc.
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Merck & Co., Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Bausch & Lomb Incorporated
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Allergan plc (a subsidiary of AbbVie Inc.)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Teva Pharmaceutical Industries Ltd.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Santen Pharmaceutical Co., Ltd.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Aerie Pharmaceuticals, Inc.
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Ocular Therapeutix, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Nicox S.A.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development